The goal of this activity is that learners will be better able to interpret and apply the most recent immunotherapy data in the clinical care of patients with solid tumors.
- Provider:Medscape, LLC
- Activity Link: https://www.medscape.org/viewarticle/immunotherapy-chronicles-unveiling-latest-data-and-2024a1000gvf
- Start Date: 2024-09-19 05:00:00
- End Date: 2024-09-19 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.25 hours
- MOC Credit Details: ABIM - 0.25 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Bristol Myers Squibb - Amount: 89504.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Hematology, Medical Oncology
Subscribe
Login
0 Comments
Oldest